Lymphatic Metastasis

• 

  Subject Areas on Research

  • A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. 
  • A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603). 
  • A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer. 
  • A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning. 
  • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. 
  • A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. 
  • A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. 
  • A model for pretest probability of lymph node metastasis from cutaneous Melanoma. 
  • A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma. 
  • A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results. 
  • A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma. 
  • A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. 
  • A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. 
  • A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181. 
  • ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil. 
  • Abdominal pain and a pelvic mass. 
  • Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. 
  • Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. 
  • Acral melanoma: a review of 185 patients with identification of prognostic variables. 
  • Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. 
  • Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. 
  • Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit. 
  • Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. 
  • Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. 
  • Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. 
  • Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry. 
  • Advanced prostatic carcinoma: pulmonary manifestations. 
  • Advances in the care of the patient with malignant melanoma. 
  • Altered lymphocyte populations in tumour invaded nodes of breast cancer patients. 
  • American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. 
  • American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. 
  • An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients. 
  • Analysis of lymph nodal metastases in malignant melanoma using the poisson probability paradigm and Bayes rule. 
  • Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. 
  • Androgen-independent prostate cancer progression in the TRAMP model. 
  • Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients. 
  • Animal models of human colorectal cancer: Current status, uses and limitations. 
  • Application of ACOSOG Z0011 criteria reduces perioperative costs. 
  • Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant? 
  • Assessment of anatomic extent and biologic hazard of prostatic adenocarcinoma. 
  • Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer. 
  • Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. 
  • Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer. 
  • Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. 
  • Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma. 
  • Axillary lymph nodes: mammographic, pathologic, and clinical correlation. 
  • BMI influences prognosis following surgery and adjuvant chemotherapy for lymph node positive breast cancer. 
  • BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. 
  • Bevacizumab-associated fistula formation in postoperative colorectal cancer patients. 
  • Bilateral pelvic lymph node metastases in a case of FIGO stage IA(1) adenocarcinoma of the cervix. 
  • Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. 
  • Breast cancer in patients with residual invasive carcinoma is more accurately staged with additive tumor size assessment. 
  • Breast cancer. Clinical practice guidelines in oncology. 
  • CT-guided hookwire placement: a technical innovation for preoperative localization of nonpalpable cervical lymph nodes. 
  • CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. 
  • Can completion lymph node dissection be avoided for a positive sentinel node in melanoma? 
  • Capromab Pendetide imaging of prostate cancer. 
  • Carcinoma of the male urethra. 
  • Carcinoma of the prostate: the therapeutic dilemma. 
  • Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. 
  • Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database. 
  • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. 
  • Chemokine receptors and melanoma metastasis. 
  • Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system. 
  • Chylothorax: a rare complication of metastatic prostatic carcinoma. 
  • Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. 
  • Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. 
  • Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study. 
  • Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. 
  • Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. 
  • Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. 
  • Colon sentinel lymph node mapping: practical surgical applications. 
  • Colonoscopic indirect lymphangiography in a canine model. 
  • Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. 
  • Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients. 
  • Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients. 
  • Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance). 
  • Comparison of plain radiography, conventional tomography, and computed tomography in detecting intrathoracic lymph node metastases from lung carcinoma. 
  • Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. 
  • Complete remission seven years after treatment for metastatic malignant melanoma. 
  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. 
  • Computed tomography in the detection of abdominal metastases from malignant melanoma. 
  • Computed tomography-guided fine-needle aspiration of retroperitoneal lymph nodes in gynecologic oncology. 
  • Controversies regarding laparoscopic colectomy for malignant diseases. 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. 
  • Cost effectiveness of a test to detect metastases for endometrial cancer. 
  • Cutaneous lymphatic drainage in patients with grossly involved nodal basins. 
  • Cutaneous squamous cell carcinoma with zosteriform metastasis in a transplant recipient. 
  • Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS. 
  • Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. 
  • Detection of Occult Micrometastases in Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance). 
  • Detection of occult N2 disease with molecular techniques. 
  • Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan. 
  • Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. 
  • Diagnosis of hematopoietic processes by fine-needle aspiration in conjunction with flow cytometry: A review of 127 cases. 
  • Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases. 
  • Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology. 
  • Differences between univariate and bivariate models for summarizing diagnostic accuracy may not be large. 
  • Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis. 
  • Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas. 
  • Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues. 
  • Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. 
  • Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. 
  • Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations. 
  • Distribution and mechanism of uptake of 111InCl3 in a tumor model for lymph node metastases. 
  • Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? 
  • Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival? 
  • Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance? 
  • Does the preparation and utilization of 99mTc-sulfur colloid affect the outcomes of breast lymphoscintigraphy? 
  • Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel. 
  • Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. 
  • Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. 
  • Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters. 
  • Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis. 
  • Economic evaluation of high-dose chemotherapy and bone marrow transplantation for patients with breast cancer of stage II or IIIA with more than 10 positive lymph nodes at surgical excision. 
  • Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. 
  • Effect of surgeon specialization on long-term survival following colon cancer resection at an NCI-designated cancer center. 
  • Effective surgical adjuvant therapy for high-risk rectal carcinoma. 
  • Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. 
  • Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason. 
  • Endoscopic ultrasound-guided fine needle aspiration is useful for nodal staging in patients with pleural mesothelioma. 
  • Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. 
  • Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma. 
  • Experience with Gleason's histopathologic grading in prostatic cancer. 
  • Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. 
  • Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. 
  • Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. 
  • Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. 
  • Extracapsular spread and the perineural extension of squamous cell cancer in the cervical plexus. 
  • Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. 
  • FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. 
  • FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. 
  • Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases. 
  • Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial. 
  • FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. 
  • Frozen section of N2 nodes is invaluable whenever unexpected suspicious operative findings are encountered. 
  • Functional airway obstruction observed with hyperpolarized 129 Xenon-MRI. 
  • Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. 
  • Future directions in regional treatment strategies for melanoma and sarcoma. 
  • Future trends in lung cancer diagnosis. 
  • Gastric adenocarcinoma: CT versus surgical staging. 
  • Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. 
  • Gene expression predictors of breast cancer outcomes. 
  • Gene expression profiling for prediction of clinical characteristics of breast cancer. 
  • Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. 
  • Genomic prediction of locoregional recurrence after mastectomy in breast cancer. 
  • Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. 
  • Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance? 
  • High dose rate intraoperative radiotherapy for recurrent cervical cancer and nodal disease. 
  • High-dose chemotherapy for breast cancer: is another look warranted? 
  • High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer. 
  • High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. 
  • High-risk cutaneous squamous cell carcinoma without palpable lymphadenopathy: is there a therapeutic role for elective neck dissection? 
  • How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. 
  • How well does the new lung cancer staging system predict for local/regional recurrence after surgery?: A comparison of the TNM 6 and 7 systems. 
  • Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. 
  • I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. 
  • Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach. 
  • Imaging bronchogenic carcinoma. 
  • Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. 
  • Imaging of thyroid carcinoma with CT and MRI: approaches to common scenarios. 
  • Immunodiagnosis of melanoma using chimpanzee antihuman melanoma antiserum. 
  • Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. 
  • Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761. 
  • Immunohistochemical expression of Ki-67 to predict lymph node involvement in clinical stage I nonseminomatous germ cell tumors. 
  • Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostate-specific antigen. 
  • Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry. 
  • Impact of PET staging in limited-stage small-cell lung cancer. 
  • Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. 
  • Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer. 
  • Impact of delayed lymphoscintigraphy for sentinel lymphnode biopsy for breast cancer. 
  • Impact of number of nodes retrieved on outcome in patients with rectal cancer. 
  • Impact of pelvic lymphadenectomy in patients with prostatic adenocarcinoma. 
  • Impact of pre-operative positron emission tomography in gallbladder cancer. 
  • In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. 
  • In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. 
  • In-transit melanoma: the role of alkylating-agent resistance in regional therapy. 
  • Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. 
  • Incidental metastatic papillary thyroid carcinoma in microvascular reconstruction. 
  • Increased erbB-2 gene copies and expression in multiple stages of breast cancer. 
  • Influence of trauma on the unusual distribution of metastases from carcinoma of the larynx. 
  • Influence of tumour size on human prostate tumour metastasis in athymic nude mice. 
  • Integrative molecular profiling of routine clinical prostate cancer specimens. 
  • Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. 
  • Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. 
  • Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. 
  • Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial. 
  • Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation. 
  • Invasive staging of non-small cell lung cancer - A review of the current evidence 
  • Invasive staging of non-small cell lung cancer: a review of the current evidence. 
  • Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases. 
  • Investigative studies in the diagnosis and treatment of melanoma. 
  • Investment in new technology research can save future health care dollars. 
  • Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis? 
  • Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. 
  • Is there a role for selective neck dissection after chemoradiation for head and neck cancer? 
  • Is there a role for sentinel lymph node biopsy in the management of sarcoma? 
  • Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. 
  • Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. 
  • LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. 
  • Late recurrence of malignant melanoma. Analysis of 168 patients. 
  • Letter: Treatment of dysgerminoma. 
  • Liver metastases from breast cancer: long-term survival after curative resection. 
  • Local failure in resected N1 lung cancer: implications for adjuvant therapy. 
  • Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data. 
  • Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. 
  • Long-term clinical outcome of immediate reconstruction after mastectomy. 
  • Long-term follow-up of a phase II trial studying a weekly doxorubicin-based multiple drug adjuvant therapy for stage II node-positive carcinoma of the breast. 
  • Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis. 
  • Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. 
  • Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. 
  • Low-Volume Lymph Node Metastases in Endometrial Carcinoma. 
  • Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. 
  • Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. 
  • Lymph node sampling in patients with epithelial ovarian carcinoma. 
  • Lymph node staging in potentially curable prostatic carcinoma. 
  • Lymph node staging of potentially curable prostatic carcinoma. 
  • Lymph nodes in colorectal carcinoma. The Poisson probability paradigm. 
  • Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. 
  • Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. 
  • Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. 
  • Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis. 
  • Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. 
  • Lymphatic mapping and sentinel node analysis: current concepts and applications. 
  • Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. 
  • Lymphatic mapping and sentinel node identification for colorectal cancer. 
  • Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. 
  • Lymphovascular invasion is associated with survival for papillary thyroid cancer. 
  • MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. 
  • Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. 
  • Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability. 
  • Malignant melanoma arising during pregnancy. A study of 100 patients. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). 
  • Melanoma immunotherapy using mature DCs expressing the constitutive proteasome 
  • Melanoma patients evaluated by four different positron emission tomography reconstruction techniques. 
  • Merkel cell carcinoma: prognosis and treatment of patients from a single institution. 
  • Metastasis-Directed Therapy: Right for Some, but Not All, and Not Here. 
  • Metastatic adenocarcinoma to the neck from an unknown primary source. 
  • Metastatic malignant melanoma with an unknown primary. 
  • Metastatic patterns in adenocarcinoma. 
  • Metastatic prostate cancer in a transgenic mouse. 
  • Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. 
  • Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma. 
  • Minimally invasive operation for breast cancer. 
  • Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications. 
  • Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761. 
  • Molecular staging of malignant melanoma: correlation with clinical outcome. 
  • Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer. 
  • Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma. 
  • Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen. 
  • NCCN Clinical Practice Guidelines Occult primary. 
  • Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. 
  • Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. 
  • Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals. 
  • Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. 
  • Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. 
  • Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. 
  • Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. 
  • Non-small cell lung cancer: FDG-PET imaging. 
  • Obesity and body fat distribution and breast cancer prognosis. 
  • Occult primary breast cancer at a comprehensive cancer center. 
  • Oncologic effectiveness of selective neck dissection in the N0 irradiated neck. 
  • Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. 
  • Optimizing the quality of breast cancer biomarker use at Duke Cancer Institute. 
  • Osteogenic sarcoma of the head and neck. The UCLA experience. 
  • Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. 
  • Overexpression of synuclein-gamma in pancreatic adenocarcinoma. 
  • Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. 
  • Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer. 
  • Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. 
  • Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. 
  • Pathologic nodal status predicts disease-free survival after neoadjuvant chemoradiation for gastroesophageal junction carcinoma. 
  • Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. 
  • Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer. 
  • Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma. 
  • Patterns of Use and Short-Term Outcomes of Minimally Invasive Surgery for Malignant Pheochromocytoma: A Population-Level Study. 
  • Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. 
  • Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. 
  • Patterns of recurrence after trimodality therapy for esophageal cancer. 
  • Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. 
  • Pelvic lymphadenectomy is not essential to staging accuracy in all patients with localized prostate cancer. 
  • Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. 
  • Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy. 
  • Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. 
  • Plasma dopamine-beta-hydroxylase in the diagnosis of neuroblastoma. 
  • Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma? 
  • Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. 
  • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. 
  • Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. 
  • Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. 
  • Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray. 
  • Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. 
  • Predictors of nodal metastasis in pediatric differentiated thyroid cancer. 
  • Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. 
  • Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer. 
  • Preoperative imaging for resectable periampullary cancer: clinicopathologic implications of reported radiographic findings. 
  • Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. 
  • Prevalence of nodal metastases in the submuscular recess (level IIb) during selective neck dissection. 
  • Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. 
  • Primary malignant fibrous histiocytoma of the lung. A clinicopathologic and ultrastructural study of five cases. 
  • Primary malignant melanoma of the scrotum. 
  • Probabilistic issues with sentinel lymph nodes in malignant melanoma. 
  • Prognosis of patients with stage D1 prostatic adenocarcinoma. 
  • Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial. 
  • Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). 
  • Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. 
  • Prognostic factors in low-stage nonseminomatous testicular cancer. 
  • Prognostic factors in renal adenocarcinoma. 
  • Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. 
  • Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. 
  • Prognostic indicators for survival in stage I carcinoma of the lung: a histologic study of 47 surgically resected cases. 
  • Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. 
  • Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining. 
  • Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. 
  • Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer. 
  • Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. 
  • Prospective studies of neck dissection specimens support preservation of sublevel IIB for laryngeal squamous carcinoma with clinically negative neck. 
  • Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. 
  • Prostatic disorders: MR imaging at 1.5 T. 
  • Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. 
  • Race, anthropometric factors, and stage at diagnosis of breast cancer. 
  • Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer. 
  • Radiation therapy versus delayed androgen deprivation for stage C carcinoma of the prostate. 
  • Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. 
  • Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. 
  • Radical pancreatoduodenectomy for cancer of the papilla of Vater. 
  • Radical surgery versus radiation therapy in early prostatic carcinoma. 
  • Radical surgery versus radiotherapy for adenocarcinoma of the prostate. 
  • Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers. 
  • Randomized multicentric study of perioperative chemotherapy with mitoxantrone in early breast cancer. 
  • Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. 
  • Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. 
  • Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. 
  • Recent developments in defining microinvasive and early invasive carcinoma of the uterine cervix. 
  • Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients. 
  • Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. 
  • Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? 
  • Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. 
  • Retroaortic left renal vein in testicular cancer patient: potential staging and treatment pitfall. 
  • Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. 
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. 
  • Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. 
  • Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis. 
  • Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. 
  • Role of EUS for the evaluation of mediastinal adenopathy. 
  • Role of salvage lymph node dissection in prostate cancer. 
  • Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial. 
  • Segmentectomy and Lung Cancer: Why, When, How, and How Good? 
  • Selection of patients for heterotopic implantation of the areola and nipple. 
  • Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck. 
  • Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study. 
  • Sentinel lymph node biopsy following a rotational flap. 
  • Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. 
  • Sentinel lymph node biopsy in melanoma of the head and neck. 
  • Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. 
  • Sentinel lymph node detection using laser-assisted indocyanine green dye lymphangiography in patients with melanoma. 
  • Sentinel node biopsy for head and neck melanoma: a systematic review. 
  • Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. 
  • Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. 
  • Sentinel node staging of resectable colon cancer: results of a multicenter study. 
  • Simultaneously detected bilateral testicular cancer of different histopathological origin--a challenging situation for the urologist. 
  • Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. 
  • Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissections? 
  • Small neuroendocrine lesions in intrathoracic lymph nodes of patients with primary lung adenocarcinoma: real metastasis? 
  • Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. 
  • Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovary. 
  • Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. 
  • Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients. 
  • Staging lymphadenectomy should not be an antecedent to treatment in localized prostatic carcinoma. 
  • Staging non-small cell lung cancer with whole-body PET. 
  • Staging of colorectal cancer: past, present, and future. 
  • Staging of esophageal cancer by EUS: staging accuracy revisited. 
  • Staging pelvic lymphadenectomy for carcinoma of the prostate risk versus benefit. 
  • Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study. 
  • Staging techniques for lung cancer. 
  • Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma. 
  • Surgical management of medullary thyroid carcinoma. 
  • Surgical management of pancreatic lymphoma. 
  • Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. 
  • Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. 
  • Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. 
  • Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. 
  • T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction? 
  • Telomerase activity and prognosis in primary breast cancers. 
  • Temporary placement of a fully covered self-expanding metal stent to allow therapeutic ERCP. 
  • Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. 
  • Testicular microlithiasis and subsequent development of metastatic germ cell tumor. 
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. 
  • The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer. 
  • The anatomy of missed breast cancers. 
  • The challenge of systematic reviews of diagnostic and staging studies in cancer. 
  • The critical role of axillary ultrasound and aspiration biopsy in the management of breast cancer patients with clinically negative axilla. 
  • The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). 
  • The effects of NSAIDs on breast cancer prognostic factors. 
  • The genomic relationship between primary breast carcinomas and their nodal metastases. 
  • The histologic response of soft tissue sarcoma to radiation therapy. 
  • The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. 
  • The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? 
  • The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. 
  • The importance of total number of sentinel lymph nodes in patients with stage N0 cutaneous melanoma. 
  • The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. 
  • The natural progression of adenocarcinoma of the epididymis. 
  • The need for standardized pathologic staging of pancreaticoduodenectomy specimens. 
  • The orderly progression of melanoma nodal metastases. 
  • The pelvis after surgery for rectal carcinoma: serial CT observations with emphasis on nonneoplastic features. 
  • The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. 
  • The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. 
  • The prognostic significance of recall antigen testing in melanoma patients. 
  • The relationship of collagenolytic activity to stage of human colorectal carcinoma. 
  • The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. 
  • The role of lymphoscintigraphy in the management of the patient with breast cancer. 
  • The role of resection in the management of melanoma metastatic to the adrenal gland. 
  • The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. 
  • The role of surgery for patients with metastatic melanoma. 
  • The sentinel node in colorectal carcinoma. Mapping technique, pathologic assessment, and clinical relevance. 
  • The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. 
  • The tumor biology of melanoma nodal metastases. 
  • The utility of thyroglobulin washout studies in predicting cervical lymph node metastases: One academic medical center's experience. 
  • The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. 
  • Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. 
  • Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer. 
  • Thyroid carcinoma: the surgeon's perspective. 
  • Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. 
  • Total circulating albumin deficits occurring with extensive surgical procedures. 
  • Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial. 
  • Transperitoneal Versus Extraperitoneal Laparoscopic Lymphadenectomy for Gynecological Malignancies: A Systematic Review and Meta-analysis. 
  • Transplanted carcinoma in an immunosuppressed patient. 
  • Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. 
  • Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. 
  • Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. 
  • Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. 
  • Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions. 
  • Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis. 
  • Unique features of breast cancer in Taiwan. 
  • Upper extremity lymphangiography as an aid to treatment planning for stage 1A epitrochlear hodgkin's disease. 
  • Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change. 
  • Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma. 
  • Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer. 
  • Validation of delayed sentinel lymph node mapping for melanoma. 
  • Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. 
  • Virtual bronchoscopy for directing transbronchial needle aspiration of hilar and mediastinal lymph nodes: a pilot study. 
  • Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? 
  • Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma. 
  • Will the global economic downturn affect prostate cancer care? Pelvic lymphadenectomy as an example. 
  • [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial. 
  • [Adjuvant therapy of surgically removed stage I melanoma]. 
  • [Clinical stage I mature teratoma of the testis--retroperitoneal lymphadenectomy or surveillance?]. 
  • [Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy]. 
  • p53 gene alterations in human prostate carcinoma. 
  • p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. 
  • ras mutations and expression in head and neck squamous cell carcinomas. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Craciunescu, Oana, Associate Professor of Radiation Oncology, Radiation Oncology
  • Hoang, Jenny K., Associate Professor of Radiology, Radiology, Neuroradiology
  • Lee, Walter T, Associate Professor of Surgery, Radiation Oncology
  • Moorman, Patricia Gripka, Professor in Community and Family Medicine, Duke Cancer Institute
  • Patz Jr., Edward F., James and Alice Chen Professor of Radiology, Pathology